44 results
6-K
EX-99.5
MDNAF
Medicenna Therapeutics Corp.
14 Feb 24
Interim condensed consolidated financial statements of
7:30am
offset by reductions in stock-based compensation and licensing fees.
General and administrative expenses of $1.8 million were incurred during
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
14 Feb 24
Interim condensed consolidated financial statements of
7:30am
.
The above increases for the nine month period ending December 31, 2023 related to the prior comparative period were partially offset by tax credits
6-K
EX-99.5
MDNAF
Medicenna Therapeutics Corp.
14 Nov 23
Interim condensed consolidated financial statements of
12:00am
and benefits due to increase in headcount, partially offset by the one-time transaction costs associated with warrant derivative in the six month period ended
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
14 Nov 23
Interim condensed consolidated financial statements of
12:00am
insurance premiums, partially offset by higher salaries and benefits, due to increased headcount to the executive leadership team. One-time transaction
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
28 Aug 23
Current report (foreign)
4:49pm
situated executives and (iii) previous grants of Options.
Hedge or Offset Instruments
Named Executive Officers or directors are not permitted … to purchase financial instruments that are designed to hedge or offset a decrease in market value of equity securities granted as compensation or held
6-K
EX-99.2
ezd10ail9njbrz1p8
28 Jul 23
Interim condensed consolidated financial statements of
8:31am
6-K
EX-99.1
5cm5h6v7jjkr75
27 Jun 23
Medicenna Reports Fiscal Year 2023 Financial Results and Operational Highlights
2:35pm
6-K
EX-99.2
w5pzt 7k2tizj87nrfz
4 Nov 22
Interim condensed consolidated financial statements of
8:00am
6-K
EX-99.5
nbzu6pgrdokv9i2r sw
4 Nov 22
Interim condensed consolidated financial statements of
8:00am
6-K
EX-99.1
zdjdx 2adyu
22 Aug 22
Current report (foreign)
11:39am
6-K
EX-99.2
c0ab03f95x14o9w8xch6
15 Aug 22
Interim Condensed Consolidated Statements of Financial Position
8:00am
SUPPL
xicm1u3jc7 yf36
10 Aug 22
Supplemental materials (foreign)
3:10pm
SUPPL
o6127yj 0wu3tmmr
8 Aug 22
Supplemental materials (foreign)
8:40pm
20-F
EX-4.7
g0683k7lqlpxb374rwg
22 Jun 22
Annual report (foreign)
5:04pm
20-F
xh7aef 5x6a
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-15.1
k09u vn1klcq
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-4.3
6jgg87fy1f
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-4.2
pz6pyn5 yc5b
22 Jun 22
Annual report (foreign)
5:04pm